You are here:

Archived: Bemiparin, 25,000 IU/ml injection for sub-cutaneous administration

Advice

Following a full submission

Bemiparin (Zibor) is not recommended for use within NHS Scotland for the treatment of established deep vein thrombosis, with or without pulmonary embolism, during the acute phase.

Greater numbers of patients had a reduction in thrombus size with bemiparin than unfractionated heparin, but bemiparin has not been compared with other low molecular heparins.

Cost effectiveness has not been demonstrated.

Drug Details

Drug Name: Bemiparin, 25,000 IU/ml injection for sub-cutaneous administration
SMC Drug ID: 206/05
Manufacturer: Amdipharm PLC
Indication: Treatment of established deep vein thrombosis, with or without pulmonary embolism, during acute phase
BNF Category:
Sub Category: 2.8 Anticoagulants and protamine
Submission Type: Full submission
Status: Not Recommended
Date Advice Published: 10 October 2005

Current Advice

Resubmission 9 July 2007

Back